Condition
Menin Inhibitors
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07559695RecruitingPrimary
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT06052813Phase 1Active Not Recruiting
A Study of BN104 in the Treatment of Acute Leukemia
NCT07101497Phase 2RecruitingPrimary
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
Showing all 3 trials